aspirin has been researched along with fibrin in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 42 (40.00) | 18.7374 |
1990's | 21 (20.00) | 18.2507 |
2000's | 18 (17.14) | 29.6817 |
2010's | 18 (17.14) | 24.3611 |
2020's | 6 (5.71) | 2.80 |
Authors | Studies |
---|---|
Aleksandrova, NA; Bokarev, IN; Kabaeva, EV; Kun, IS; Marcukova, EV; Olbinskaja, LI; Ovcinnikova, LV | 1 |
Buchanan, MR; Carter, CJ; Hirsh, J; Kelton, JG | 1 |
Geuze, JJ; Sixma, JJ; van der Veen, J; Wester, J | 1 |
Dalldorf, FG; Jennette, JC; Tullar, JC; Upton, GW | 1 |
Bjørnson, J; Brosstad, F | 1 |
Dixon, M; Farrell, PC; Stewart, JH | 1 |
Baxter, CR; Curreri, PW; Wilterdink, ME | 1 |
Ditter, H; Matthias, FR | 1 |
Cooley, BC; Gould, JS; Savoie, FH | 1 |
Himmelreich, G; Riess, H | 1 |
Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
Berger, H; Bjornsson, TD; Schneider, DE | 1 |
Hu, SJ; Jen, CJ | 1 |
Cerletti, C; de Gaetano, G; Dejana, E; Vermylen, J | 1 |
Cooley, BC; Ruas, EJ; Wilgis, EF | 1 |
Berger, H; Kirstein, CG; Tuttle, PR | 1 |
Heady, JA; O'Brien, JR; Tulevski, V | 1 |
Quick, AJ | 1 |
Chang, YH; Wiseman, EH | 1 |
Berger, KE; Mansfield, PB; Overton, JB; Sauvage, LR; Smith, JC; Wood, SJ | 1 |
Smit Sibinga, CT | 1 |
Iatridis, PG; Iatridis, SG; Markidou, SG; Ragatz, BH | 1 |
Beys-Col, CD; Masure, R; Moriau, M; Noel, H; Rodhain, J | 1 |
Hampton, J | 1 |
Parr, EL | 1 |
Genton, E; Steele, PP; Weily, HS | 1 |
Beller, FK; Slabber, CF; Theiss, W | 1 |
George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
De Gaetano, G; Donati, MB; Palester-Chlebowczyk, M; Vermylen, J | 1 |
Amir, J; Krauss, S | 1 |
Arrington, PJ; McNamara, JJ | 1 |
Ardlie, NG; Han, P | 1 |
Rosenior, JC; Tonks, RS | 1 |
Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS | 1 |
Larrieu, MJ | 1 |
Kubisz, P; Larrieu, MJ; Rigollot, C | 1 |
de Gaetano, G | 1 |
Glaves, D; Weiss, L | 1 |
Granström, E; Lundström, V; Swahn, ML | 1 |
Butler, KD; Maguire, ED; Smith, JR; Turnbull, AA; Wallis, RB; White, AM | 1 |
Bertelé, V; Cerletti, C; de Gaetano, G; Di Minno, G; Silver, MJ | 1 |
Housholder, GT; Moorrees, LL | 1 |
Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
Baumgartner, HR; Turitto, VT; Vicic, WJ; Weiss, HJ | 1 |
Balconi, G; Barbieri, B; Dejana, E; Donati, MB | 1 |
Bernier, J; Guidoin, R; Marois, Y; Merhi, Y | 1 |
Buchwald, AB; Ebbecke, M; Lüders, S; Munz, DL; Nebendahl, K; Sandrock, D; Unterberg, C; Wiegand, V | 1 |
Roald, HE; Sakariassen, KS | 1 |
Chang, MC; Huang, TF; Wang, CY | 1 |
Bakken, IJ; Barstad, RM; Kierulf, P; Orvim, U; Roald, HE; Sakariassen, KS | 1 |
Carr, ME; Dent, RM; Greilich, PE; Zekert, SL | 1 |
Beretz, A; Cazenave, JP; Freund, M; Gachet, C; Mantz, F; Meyer, L; Mulvihill, J; Nicolini, P | 1 |
Debruyne, FM; Doesburg, W; vd Meijden, AP; Witjes, JA | 1 |
Schächinger, V; Zeiher, AM | 1 |
Chesebro, JH; Fuster, V; Grill, DE; Heras, M; Holmes, DR; Mruk, JS; Webster, MW; Zoldhelyi, P | 1 |
Durham, SK; Megill, JR; Schumacher, WA; Steinbacher, TE | 1 |
Diederich, KW; Garbe, M; Mitusch, R; Sheikhzadeh, A; Siemens, HJ; Wagner, T | 1 |
Blombäck, M; Fatah, K; Ivert, T; Williams, S | 1 |
Bärtsch, P; Hauer, K; Kälberer, B; Kübler, W; Niebauer, J; Velich, T; Weiss, C | 1 |
Ambrose, JA; Badimon, JJ; Coller, BS; Dangas, G; Fallon, JT; Hayes, RM; Marmur, JD; Meraj, P; Sharma, SK | 1 |
Blombäck, M; Dumitrescu, A; Intonti, M; Ivert, T; Stain-Malmgren, R | 1 |
Blombäck, M; Fatah, K; Hjemdahl, P; Williams, S | 1 |
Dzirlo, L; Eichler, HG; Hollenstein, U; Jilma, B; Kapiotis, S; Pernerstorfer, T; Speiser, W; Stohlawetz, P | 1 |
Bigham, M; Despotis, GJ; Saleem, R; Spitznagel, E | 1 |
Haug, KB; Joø, GB; Kierulf, P; Osnes, LT; Ovstebø, R; Westvik, AB | 1 |
Collet, JP; Lesty, C; Mishal, Z; Montalescot, G; Soria, C; Soria, J; Thomas, D | 1 |
Sobel, BE | 1 |
Ehlers, R; Helber, U; Hoffmeister, HM; Kazmaier, S; Letsch, R; Szabo, S; Walter, T | 1 |
Bozarth, JM; Feuerstein, GZ; Mousa, SA; Seiffert, D | 1 |
Boneu, B; Cadroy, Y; Sakariassen, K; Thalamas, C | 1 |
Gao, X; Han, F; Liu, X; Yang, X; Yao, W | 1 |
Antovic, A; Blombäck, M; Ekman, GJ; He, S; Hjemdahl, P; Perneby, C; Wallen, HN | 1 |
Brummel-Ziedins, KE; Mann, KG; Undas, A | 1 |
Badimon, L; Casaní, L; Vilahur, G | 1 |
Kostka, B; Para, J; Sikora, J | 1 |
Brewster, LP; Brey, EM; Burgess, WH; Calceterra, J; Gassman, A; Greisler, HP; Hall, CL; Subramanian, A; Velander, WH; Washington, C; Wolf, W | 1 |
Buerke, M; Carter, JM; Hauroeder, B; Maegdefessel, L; Michel, T; Peetz, D; Reindl, I; Schlitt, A; Schubert, S; Werdan, K | 1 |
Bhattacharya, G; Bhattacharya, R; Bhattacharyya, M; Karmohapatra, SK; Sinha, AK | 1 |
Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, H; Hemetsberger, R; Huber, K; Pavo, I; Petrasi, Z; Posa, A; Sperker, W; Strehblow, C | 1 |
Bark, N; Blombäck, M; He, S; Svensson, J; Wang, H | 1 |
Bauriedel, G; Nickenig, G; Skowasch, D; Tuleta, I; Viktor, A | 1 |
Gajos, G; Nessler, J; Piwowarska, W; Rostoff, P; Undas, A; Zalewski, J | 1 |
Adamson, U; Antovic, A; Jörneskog, G; Lins, PE; Mageed, K; Mobarrez, F; Tehrani, S; Wallén, HN | 1 |
White, H | 1 |
Ajjan, R; Grove, EL; Hess, K; Hvas, AM; Kristensen, SD; Larsen, SB; Neergaard-Petersen, S | 1 |
Bliden, KP; Gurbel, PA; Jeong, YH; Shuldiner, AR; Tantry, US | 1 |
Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
Bitar, A; Breall, JA; Desta, Z; Flockhart, DA; Jin, Y; Kreutz, RP; Nystrom, P; Owens, J; Sinha, A; Vatta, M; von der Lohe, E | 1 |
Ajjan, RA; Grant, PJ; Grove, EL; Hvas, AM; Kristensen, SD; Kurdee, Z; Larsen, SB; Neergaard-Petersen, S; Phoenix, F | 1 |
Brummel-Ziedins, K; Mann, KG; Undas, A | 1 |
Aggarwal, R; Ajjan, RA; Ariëns, RA; Bailey, MA; Bridge, KI; Griffin, KJ; Iqbal, F; Johnson, AB; Phoenix, F; Purdell-Lewis, J; Scott, DJ; Thomas, T | 1 |
Bogaert, J; Doulaptsis, K; Nessler, J; Ntoumpanaki, M; Sadowski, M; Undas, A; Woznicka, O; Ząbczyk, M; Zalewski, J | 1 |
Ghosh, K; Mukherjee, S; Patil, R; Shetty, S | 1 |
Al-Khaled, M; Eggers, J; Gärtner, U; Roessler, FC; Schumacher, S; Sprenger, A | 1 |
Adams, S; Russell, S; Wargon, O; Zhuo, KY | 1 |
Biolik, G; Kokot, M; Pawlicki, K; Święszek, A; Sznapka, M; Ziaja, D; Ziaja, K | 1 |
Abdulghani, S; Gruslin, A; Grynspan, D; Moretti, F | 1 |
Canino, J; Canobbio, I; Guidetti, GF; Torti, M; Visconte, C; Zarà, M | 1 |
Undas, A; Zabczyk, M | 1 |
Ajjan, RA; Grove, EL; Hvas, AM; Kristensen, SD; Larsen, SB; Neergaard-Petersen, S | 1 |
Ajjan, RA; Barwari, T; Grant, PJ; Mayr, M; Parker, WAE; Pearson, SM; Phoenix, F; Schulte, C; Storey, RF | 1 |
Bryk, AH; Undas, A; Wiśniewski, JR; Zettl, K | 1 |
Bree, KK; Dinney, CP; Hensley, PJ; Kamat, AM; Lobo, N; Navai, N; Nogueras-Gonzalez, GM | 1 |
Doyu, M; Ito, H; Kimura, M; Matsuyama, K; Niwa, JI | 1 |
Alieva, AK; Antonova, OA; Dobrovolsky, AB; Khaspekova, SG; Mazurov, AV; Muravlev, IA; Pevzner, DV | 1 |
15 review(s) available for aspirin and fibrin
Article | Year |
---|---|
Morphology of the early hemostasis in human skin wounds: influence of acetylsalicylic acid.
Topics: Adult; Aspirin; Blood Platelets; Cell Membrane; Fibrin; Hemostasis; Humans; Male; Microscopy, Electron; Pseudopodia; Skin; Time Factors; Wounds, Penetrating | 1978 |
Current issues in thrombosis prevention with antiplatelet drugs.
Topics: Aspirin; Cell Division; Coronary Artery Bypass; Coronary Disease; Endothelium; Epoprostenol; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Muscle, Smooth, Vascular; Platelet Adhesiveness; Platelet Aggregation; Receptors, Prostaglandin; Regional Blood Flow; Thrombosis; Thromboxane-A Synthase | 1986 |
Hemostasis in surgical procedures.
Topics: Acetylcholine; Antimetabolites; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Aggregation; Clot Retraction; Dicumarol; Epinephrine; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans; Prothrombin; Prothrombin Time; Surgical Procedures, Operative; Thrombin; Vasoconstrictor Agents; Vasodilator Agents; Vitamin K | 1969 |
Trends in the development of antithrombotic agents.
Topics: Adenine Nucleotides; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticoagulants; Aspirin; Blood Platelets; Butyrates; Dextrans; Dietary Fats; Dipyridamole; Ethylestrenol; Fibrin; Fibrinolytic Agents; Histamine H1 Antagonists; Humans; Phenformin; Phenylbutazone; Platelet Adhesiveness; Povidone; Prostaglandins; Pulmonary Embolism; Rabbits; Streptodornase and Streptokinase; Thrombophlebitis; Thrombosis; Vasodilator Agents; Venoms | 1971 |
Platelets, thrombosis and coronary artery disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Blood Protein Disorders; Cell Survival; Coronary Disease; Endothelium; Fibrin; Humans; Lipid Metabolism; Lipoproteins; Phagocytosis; Platelet Adhesiveness; Prostaglandins; Pyrazoles; Pyrimidines; Thrombosis | 1973 |
Platelets, prostaglandins and thrombotic disorders.
Topics: Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Calcium; Coronary Disease; Cyclic AMP; Diabetes Mellitus; Dietary Fats; Female; Fibrin; Humans; Myeloproliferative Disorders; Nephrotic Syndrome; Oxygenases; Platelet Adhesiveness; Platelet Aggregation; Pre-Eclampsia; Pregnancy; Prostaglandins; Thrombosis | 1981 |
Cancer cell damage at the vascular endothelium.
Topics: Animals; Aspirin; Blood Vessels; Capillaries; Endothelium; Fibrin; Heparin; Lung Neoplasms; Microcirculation; Neoplasm Metastasis; Neoplasms; Platelet Aggregation; Warfarin | 1983 |
The possible roles of prostaglandins and related compounds in endometrial bleeding. A mini-review.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Endometrium; Endothelium; Epoprostenol; Female; Fibrin; Hemostasis; Humans; Intrauterine Devices; Menstruation; Prostaglandin Endoperoxides; Prostaglandins; Thromboxane A2; Uterine Hemorrhage; Uterus | 1983 |
[New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
Topics: Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; Coronary Thrombosis; Fibrin; Heparin; Hirudin Therapy; Hirudins; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy | 1995 |
Fibrin specificity of plasminogen activators, rebound generation of thrombin, and their therapeutic implications.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Dogs; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Myocardial Infarction; Plasminogen Activators; Rabbits; Terminology as Topic; Thrombin; Tissue Plasminogen Activator | 2001 |
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.
Topics: Aspirin; Drug Resistance; Fibrin; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Thrombin | 2007 |
Targeting therapy to the fibrin-mediated pathophysiology of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Blood Coagulation; Fibrin; Humans; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12; Thrombosis | 2014 |
Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Fibrin; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Recurrence; Thrombin; Treatment Outcome; Venous Thromboembolism | 2014 |
Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options.
Topics: Anticoagulants; Aspirin; Child; Disseminated Intravascular Coagulation; Fibrin; Heparin; Humans; Risk Factors; Vascular Malformations | 2017 |
Antithrombotic medications and their impact on fibrin clot structure and function.
Topics: Anticoagulants; Aspirin; Fibrin; Fibrinolytic Agents; Humans; Purinergic P2Y Receptor Antagonists; Thrombosis; Vitamin K | 2018 |
15 trial(s) available for aspirin and fibrin
Article | Year |
---|---|
Characterization of elevated fibrin split products following thermal injury.
Topics: Aspirin; Burns; Disseminated Intravascular Coagulation; Drug Evaluation; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Heparin; Humans; Immunoassay; Prospective Studies; Staphylococcus | 1975 |
Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Creatinine; Female; Fibrin; Fibrinogen; Glomerulonephritis; Humans; Indomethacin; Kidney Glomerulus; Male; Middle Aged; Plasminogen; Prednisone; Proteinuria; Time Factors; Urea | 1972 |
Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
Topics: Adult; Aspirin; Bleeding Time; Blood; Blood Coagulation Tests; Blood Platelets; Cell Adhesion; Citrates; Dipyridamole; Endothelium; Fibrin; Humans; Male; Platelet Aggregation; Platelet Count | 1981 |
Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
Topics: Aged; Anticoagulants; Antithrombin III; Aspirin; Atrial Fibrillation; Biomarkers; Blood Coagulation; Blood Proteins; Echocardiography, Transesophageal; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Mitral Valve; Partial Thromboplastin Time; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prospective Studies; Prothrombin; Risk; Thromboembolism; Tissue Plasminogen Activator; Warfarin | 1996 |
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; Drug Therapy, Combination; Female; Fibrin; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Thrombosis | 1998 |
Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid.
Topics: Adenosine Triphosphate; Adult; Aged; Angina, Unstable; Aprotinin; Aspirin; Blood Loss, Surgical; Blood Transfusion; Cardiopulmonary Bypass; Confidence Intervals; Dose-Response Relationship, Drug; Female; Fibrin; Fibrinolytic Agents; Hemostatics; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Adhesiveness; Platelet Count; Preoperative Care; Reference Values; Treatment Outcome | 1998 |
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antigens; Antithrombin III; Aspirin; Blood Coagulation; Dimerization; Double-Blind Method; Factor VII; Factor VIIa; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Leukocyte Count; Lipopolysaccharides; Monocytes; Neutrophils; NF-kappa B; Peptide Fragments; Platelet Count; Protein C; Protein Precursors; Prothrombin; Solubility; Thromboplastin | 1999 |
The effect of epsilon-aminocaproic acid on HemoSTATUS and kaolin-activated clotting time measurements.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Aspirin; Blood Coagulation; Cardiac Surgical Procedures; Female; Fibrin; Humans; Kaolin; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Whole Blood Coagulation Time | 2000 |
Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Topics: Aged; alpha-2-Antiplasmin; Anticoagulants; Antifibrinolytic Agents; Antithrombin III; Aspirin; Biomarkers; Enzyme Activation; Factor XIIa; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Platelet Aggregation Inhibitors; Prothrombin; Recombinant Proteins; Substrate Specificity; Tenecteplase; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |
Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans.
Topics: Amidines; Aspirin; Blood Coagulation; Calcium Chloride; Cross-Over Studies; Fibrin; Humans; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reference Values; Thrombelastography | 2005 |
Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Topics: Adolescent; Adult; Arteries; Aspirin; Clopidogrel; Collagen; Cross-Over Studies; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Fibrin; Humans; Immunoenzyme Techniques; Male; Perfusion; Platelet Adhesiveness; Platelet Function Tests; Thrombosis; Ticlopidine | 2005 |
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study.
Topics: Anticoagulants; Aspirin; Cardiac Catheterization; Enoxaparin; Eptifibatide; Erythrocytes; Fibrin; Fibrinolytic Agents; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Peptide Fragments; Peptides; Perfusion; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombosis | 2008 |
Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Coagulation; C-Reactive Protein; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Dinoprost; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fibrin; Humans; Linear Models; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Poland; Prospective Studies; Prothrombin; Thrombin; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.
Topics: Aspirin; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Drug Administration Schedule; Female; Fibrin; Glycated Hemoglobin; Humans; Male | 2012 |
Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.
Topics: Aged; Aspirin; Biomarkers; Blood Coagulation; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrin; Humans; Male; MicroRNAs; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Primary Prevention; Secondary Prevention; Thrombosis; Time Factors; Treatment Outcome | 2020 |
75 other study(ies) available for aspirin and fibrin
Article | Year |
---|---|
[Clinical aspects of control in therapy with platelet inhibitors].
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Tests; Blood Platelets; Coronary Disease; Fibrin; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Factor 4; Propranolol | 1979 |
Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.
Topics: Animals; Aspirin; Blood Coagulation; Blood Vessels; Dose-Response Relationship, Drug; Epoprostenol; Fibrin; Prostaglandins; Rabbits; Salicylates; Serotonin; Veins | 1978 |
Experimental meningococcal septicemia. Effect of aspirin therapy.
Topics: Animals; Aspirin; Female; Fibrin; Kidney Glomerulus; Kidney Tubular Necrosis, Acute; Lung; Meningococcal Infections; Rabbits; Sepsis; Shock, Septic | 1978 |
Platelet and fibrin(ogen) deposition in the artificial kidney. The influence of haematocrit, fibrin monomer and platelet inhibitors. An in vitro study.
Topics: Aspirin; Blood Platelets; Chromium Radioisotopes; Fibrin; Fibrinogen; Hematocrit; Heparin; Humans; Iodine Radioisotopes; Kidneys, Artificial; Prostaglandins E | 1978 |
Reduction of platelet/fibrin deposition in haemodialysers by aspirin administration.
Topics: Adult; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Depression, Chemical; Female; Fibrin; Humans; Kidneys, Artificial; Male; Middle Aged; Platelet Aggregation; Renal Dialysis; Time Factors | 1975 |
The effects of an infusion of prostacyclin on their endotoxin shock in rabbits.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Blood Pressure; Carbon Dioxide; Epoprostenol; Fibrin; Fibrinogen; Lactates; Lactic Acid; Leukocyte Count; Oxygen; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Prothrombin Time; Rabbits; Shock, Septic; Survival Analysis; Thromboxane B2 | 1990 |
Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: a scanning electron microscopy study.
Topics: Animals; Arteries; Aspirin; Dextrans; Ear, External; Endothelium, Vascular; Femoral Artery; Fibrin; Fibrinolytic Agents; Heparin; Microscopy, Electron, Scanning; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Streptokinase; Thrombosis; Time Factors; Vascular Patency | 1991 |
[Recurrent thromboembolism due to increased acetylsalicylic acid-resistant platelet aggregation].
Topics: Aspirin; Fibrin; Humans; Male; Middle Aged; Platelet Aggregation; Recurrence; Thromboembolism; Ticlopidine | 1991 |
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
Topics: Acetylation; Aspirin; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Kinetics; Male; Plasminogen Activators; Reference Values | 1989 |
Direct platelet-fibrin interaction that does not require platelet activation.
Topics: Adenosine Diphosphate; Alprostadil; Aspirin; Blood Platelets; Egtazic Acid; Fibrin; HEPES; Humans; Hydrogen-Ion Concentration; Kinetics; Nephelometry and Turbidimetry; Oligopeptides; Platelet Aggregation; Polymers; Serotonin | 1987 |
Scanning electron microscopy of crush/avulsion arterial trauma:effect of heparin and aspirin administration.
Topics: Animals; Arteries; Aspirin; Blood Coagulation; Blood Platelets; Femoral Artery; Fibrin; Heparin; Microscopy, Electron, Scanning; Platelet Aggregation; Rats; Rats, Inbred Strains; Thrombosis; Vascular Patency | 1987 |
Quantitative assessment of subcutaneous fibrinolysis in the rat.
Topics: Animals; Aspirin; Blood Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinolysis; Male; Rats; Rats, Inbred Strains; Skin; Time Factors | 1986 |
Rate of fibrinogen turnover in thrombosis.
Topics: Age Factors; Analysis of Variance; Aspirin; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Methods; Placebos; Postoperative Complications; Thrombosis; Time Factors | 1972 |
The role of fibrin in the inflammatory response to carrageenin.
Topics: Animals; Aspirin; Blood Coagulation; Carrageenan; Edema; Fibrin; Fibrinolysin; Heparin; Indenes; Male; Phenylbutazone; Prothrombin; Rats; Thrombin; Time Factors; Vitamin K | 1968 |
Future directions in the development of arterial prostheses for small and medium caliber arteries.
Topics: Animals; Arteries; Aspirin; Blood Flow Velocity; Blood Vessel Prosthesis; Dipyridamole; Endothelium; Fibrin; Forecasting; Hematoma; Humans; Platelet Adhesiveness; Polyethylene Terephthalates; Prosthesis Design; Sutures; Textiles; Thrombosis; Time Factors; Wound Healing | 1974 |
Prevention of vessel wall damage in experimental irradiation.
Topics: Animals; Antifibrinolytic Agents; Aspirin; Blood Coagulation; Blood Vessels; Carotid Arteries; Cyclohexanecarboxylic Acids; Fibrin; Fibrinogen; Glycosaminoglycans; Heparin; Lipid Metabolism; Methylamines; Platelet Adhesiveness; Prednisone; Rabbits; Radiation Injuries, Experimental | 1973 |
In vitro effects of aspirin in fibrinolysis.
Topics: Animals; Aspirin; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Chickens; Factor XII; Fibrin; Fibrinolysin; Fibrinolysis; Humans; Plasminogen; Serum Globulins; Streptokinase; Urokinase-Type Plasminogen Activator | 1974 |
Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
Topics: Aminocaproates; Animals; Aprotinin; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Enzyme Activation; Enzyme Inhibitors; Fibrin; Fibrinogen; Fibrinolysin; Heparin; Heparin Antagonists; Kidney; Lung; Methylamines; Plasminogen; Platelet Aggregation; Protease Inhibitors; Thrombin; Thromboplastin | 1974 |
Histological examination of the rat ovarian follicle wall prior to ovulation.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Chorionic Gonadotropin; Collagen; Erythrocytes; Female; Fibrin; Granulosa Cells; Microscopy, Electron; Ovarian Follicle; Ovulation; Rats; Sodium Chloride; Sodium Salicylate; Theca Cells; Time Factors | 1974 |
The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds.
Topics: Animals; Aspirin; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Injections, Intravenous; Kidney Glomerulus; Microcirculation; Morpholines; Pyrimidines; Rabbits; Thiophenes | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
Platelet factor-4--properties and clinical significance.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Fibrin; Freezing; Glomerulonephritis; Heparin Antagonists; Humans; Indomethacin; Microcirculation; Serotonin | 1972 |
Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.
Topics: Adolescent; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrin; Hematocrit; Heparin; Humans; Hydrocortisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Reticulocytes; Spleen; Splenectomy | 1973 |
Effect of aspirin on microaggregate formation in banked blood.
Topics: Adult; Aspirin; Blood Banks; Blood Preservation; Fibrin; Fibrinogen; Humans; Male; Platelet Adhesiveness; Thrombin | 1974 |
Platelet aggregation and release by ADP and thrombin: evidence for two separate effects of ADP on platelets, involvement of fibrinogen in release, and mechanism of inhibitory action of acetylsalicylic acid.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelets; Fibrin; Fibrinogen; Heparin; Humans; In Vitro Techniques; Models, Biological; Models, Theoretical; Platelet Adhesiveness; Prothrombin; Pyrophosphatases; Spectrophotometry; Surface Properties; Thrombin | 1974 |
Salicylate inhibition of in vitro plasminogen activation by saline extracts of rat tissues.
Topics: Animals; Aspirin; Brain; Enzyme Activation; Fibrin; Kidney; Liver; Lung; Male; Muscles; Myocardium; Plasminogen; Rats; Salicylates; Sodium Chloride; Time Factors; Tissue Extracts | 1974 |
Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation.
Topics: Acid Phosphatase; Adenosine Diphosphate; Antigens; Aspirin; Blood Coagulation; Chromatography, Gel; Collagen; Dialysis; Epinephrine; Fibrin; Fibrinogen; Hot Temperature; Humans; Hydrogen-Ion Concentration; Molecular Weight; Phosphoenolpyruvate; Platelet Adhesiveness; Pyruvate Kinase; Solubility; Thrombin | 1971 |
Platelet aggregation induced by soluble fibrin monomer complexes.
Topics: Acid Phosphatase; Adenine Nucleotides; Aspirin; Blood Coagulation; Blood Platelets; Fibrin; Fibrinogen; Humans; Nucleosides; Platelet Adhesiveness; Pyruvate Kinase; Pyruvates | 1970 |
Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arthus Reaction; Aspirin; Bleeding Time; Blood Coagulation; Collagen; Dose-Response Relationship, Drug; Fibrin; Imidazoles; Male; Oxidoreductases; Platelet Aggregation; Platelet Count; Rabbits; Rats; Rats, Inbred Strains; Tail; Thromboxane-A Synthase | 1982 |
Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Clot Retraction; Epoprostenol; Fatty Acids, Unsaturated; Fibrin; Humans; Imidazoles; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins D; Prostaglandins E; Prostaglandins H; Prostaglandins, Synthetic; Thromboxane B2 | 1982 |
Fibrinolysis in the rat after short-term aspirin therapy.
Topics: Animals; Aspirin; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrinolysis; Male; Plasminogen Activators; Rats; Serum Globulins | 1980 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Diseases; Coronary Disease; Dipyridamole; Female; Fibrin; Humans; Male; Prostaglandins; Sex Factors; Sulfinpyrazone; Thrombosis | 1980 |
Evidence that vascular endothelial cells can induce the retraction of fibrin clots.
Topics: Animals; Aorta; Aspirin; Batroxobin; Cattle; Cells, Cultured; Clot Retraction; Endothelium; Female; Fibrin; Humans; Kinetics; Muscle, Smooth, Vascular; Pregnancy; Thrombin; Umbilical Veins | 1981 |
Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
Topics: Administration, Oral; Analysis of Variance; Animals; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Dogs; Epoprostenol; Female; Fibrin; Heparin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polyesters; Renal Circulation; Thrombin Time; Thrombosis | 1995 |
Platelet and fibrin deposition on coronary stents in minipigs: effect of hirudin versus heparin.
Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Coronary Thrombosis; Dextrans; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Fibrin; Heparin; Hirudin Therapy; Hirudins; Indium Radioisotopes; Male; Platelet Aggregation; Recombinant Proteins; Stents; Swine; Swine, Miniature; Time Factors | 1993 |
Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood. Anti-platelet drugs impair thrombus growth and increase platelet-collagen adhesion.
Topics: Aspirin; Blood Coagulation; Clopidogrel; Collagen; Fibrin; Hemorheology; Humans; Male; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Smoking; Stress, Mechanical; Surface Properties; Ticlopidine | 1995 |
Ancrod-formed fibrin stimulates prostacyclin production of human umbilical vein endothelial cells via de novo synthesis of cyclooxygenase.
Topics: 6-Ketoprostaglandin F1 alpha; Ancrod; Aspirin; Blotting, Western; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelium, Vascular; Epoprostenol; Fibrin; Humans; Kinetics; Oligopeptides; Prostaglandin-Endoperoxide Synthases; Umbilical Veins | 1994 |
Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion.
Topics: Adult; Arteries; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Adhesion; Collagen; Constriction, Pathologic; Female; Fibrin; Fibrinopeptide A; Hematocrit; Humans; Male; Middle Aged; Platelet Count; Smoking; Thrombosis | 1994 |
Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease.
Topics: Adult; Aspirin; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrin; Humans; Platelet Activation; Thrombin | 1994 |
Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Topics: Animals; Anticoagulants; Arterio-Arterial Fistula; Aspirin; Carotid Artery Thrombosis; Clopidogrel; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrin; Fibrinogen; Fibrinolytic Agents; Glass; Heparin; Hirudin Therapy; Hirudins; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyethylenes; Rats; Rats, Wistar; Recombinant Proteins; Regional Blood Flow; Silicones; Thrombin; Ticlopidine | 1993 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Coumarins; Dipyridamole; Fibrin; Humans; Male; Random Allocation; Urinary Bladder Neoplasms; Warfarin | 1993 |
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Topics: Animals; Aspirin; Blood Platelets; Carotid Arteries; Drug Therapy, Combination; Fibrin; Fibrinolytic Agents; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Swine; Thrombosis; Time Factors; Tissue Plasminogen Activator | 1996 |
A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Carotid Arteries; Carotid Artery Injuries; Collagen; Disease Models, Animal; Electric Stimulation; Ferrets; Fibrin; Humans; In Vitro Techniques; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prothrombin Time; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Species Specificity; Thrombosis; Thromboxane A2; Vasoconstrictor Agents | 1996 |
The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator.
Topics: Angina Pectoris; Aspirin; Fibrin; Humans; Time Factors; Tissue Plasminogen Activator | 1995 |
Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease.
Topics: Adult; Aged; Aspirin; Blood Coagulation; Coronary Disease; Exercise Therapy; Fibrin; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombin | 1998 |
Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid.
Topics: Adult; Antithrombin III; Aspirin; Dose-Response Relationship, Drug; Female; Fibrin; Fibrinolysis; Fibrinolytic Agents; Gels; Humans; Male; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Porosity; Prospective Studies; Thromboxanes | 1998 |
Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood.
Topics: Aspirin; Blood Cells; Dinoprostone; Dose-Response Relationship, Drug; Fibrin; Fibrinopeptide A; Humans; Interleukin-10; Lipopolysaccharides; Monocytes; Peptide Fragments; Prothrombin; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha | 2000 |
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Platelets; Blood Viscosity; Cell Membrane Permeability; Elasticity; Fibrin; Fibrinolysis; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 2001 |
Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
Topics: Animals; Antibodies; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chromatography, Gel; Dose-Response Relationship, Drug; Factor Xa; Fibrin; Fibrinogen; Formamides; Fungi; In Vitro Techniques; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Weight; Partial Thromboplastin Time; Platelet Aggregation; Polysaccharides; Prothrombin Time; Pyridines; Rabbits; Spectroscopy, Fourier Transform Infrared; Sulfates; Sulfonic Acids; Sulfuric Acid Esters; Thrombin; Thrombin Time | 2005 |
Marked increase of fibrin gel permeability with very low dose ASA treatment.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolytic Agents; Gels; Humans; Imaging, Three-Dimensional; Male; Microscopy, Confocal; Permeability; Platelet Aggregation Inhibitors; Porosity; Time Factors | 2005 |
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Topics: Administration, Oral; Animals; Aorta; Aspirin; Bleeding Time; Blood Coagulation; Clopidogrel; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Naphthalenes; Platelet Activation; Platelet Aggregation Inhibitors; Propionates; Prosthesis Design; Receptors, Thromboxane A2, Prostaglandin H2; Stainless Steel; Stents; Swine; Thrombosis; Ticlopidine; Time Factors | 2007 |
A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
Topics: Antifibrinolytic Agents; Aspirin; Blood Coagulation Tests; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Monitoring; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Multiphasic Screening; Research Design; Software; Thrombin; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2007 |
Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.
Topics: Aspirin; Binding Sites; Cells, Cultured; Chemotaxis; Collagen; Drug Combinations; Enzyme Activation; Fibrin; Fibroblast Growth Factors; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitosis; Protein Binding; Sensitivity and Specificity; Succinic Acid; Thrombin | 2008 |
The role of leucocytes in the acetyl salicylic acid (aspirin) induced nitric oxide synthesis in the production of interferon-alpha, a potent inhibitor of platelet aggregation and a thrombolytic agent.
Topics: Adenosine Diphosphate; Adult; Animals; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Female; Fibrin; Fibrinolysis; Humans; Interferon-alpha; Leukocytes; Male; Mice; Middle Aged; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Thrombosis | 2009 |
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aspirin; Cell Proliferation; Clopidogrel; Collagen; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Hyperplasia; Inflammation Mediators; Metals; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Swine; Ticlopidine; Time Factors; Tunica Intima | 2008 |
Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
Topics: Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Gels; Humans; Permeability; Porosity; Salicylic Acid; Thrombin; Up-Regulation | 2009 |
Diabetes mellitus is associated with increased ex vivo-platelet aggregation and decreased response to aspirin - antithrombotic potential of ACE-inhibitors and AT1-antagonists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Coronary Disease; Diabetes Mellitus, Type 2; Female; Fibrin; Humans; Hypertension; Middle Aged; Platelet Aggregation | 2009 |
Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure.
Topics: Aged; Aspirin; Blood Coagulation; Blood Platelets; C-Reactive Protein; Coronary Artery Disease; Female; Fibrin; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Treatment Failure | 2013 |
Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.
Topics: Aged; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Fibrin; Genetic Testing; Genotype; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Polymorphism, Genetic; Predictive Value of Tests; Prognosis; Thrombelastography; Thrombin; Ticlopidine; Treatment Outcome | 2014 |
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis | 2014 |
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Topics: Adult; Aged; Amino Acid Substitution; Aspirin; Clopidogrel; Coronary Artery Disease; Factor XIII; Female; Fibrin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombelastography; Ticlopidine | 2014 |
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Topics: Aged; Aspirin; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Complement C3; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation Mediators; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation Inhibitors; Registries; Risk Factors; Sex Factors; Time Factors | 2014 |
Aspirin therapy is associated with less compact fibrin networks and enhanced fibrinolysis in patients with abdominal aortic aneurysm.
Topics: Aged; Aortic Aneurysm, Abdominal; Aspirin; Case-Control Studies; Fibrin; Fibrinolysis; Humans; Male; Middle Aged | 2015 |
Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction.
Topics: Aged; Aspirin; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Erythrocytes; Female; Fibrin; Fibrinolysis; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Permeability; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Porosity; Suction; Thrombectomy; Ticlopidine; Time Factors | 2015 |
Does consumption of platelet-derived microparticles in the fibrin clot explain the decrease in their percentage during pregnancy?
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Blood Platelets; Cell-Derived Microparticles; Female; Fibrin; Heparin; Humans; Phosphatidylserines; Placenta; Pregnancy; Pregnancy Trimesters; Thrombosis | 2016 |
Clot Formation in the Presence of Acetylsalicylic Acid Leads to Increased Lysis Rates Regardless of the Chosen Thrombolysis Strategy.
Topics: Aspirin; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Kinetics; Plasminogen Activators; Thrombolytic Therapy; Ultrasonic Therapy | 2016 |
Platelet reactivity in thromboelastometry. Revision of the FIBTEM test: a basic study.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Coagulation Tests; Blood Platelets; Collagen; Cytochalasin D; Female; Fibrin; Fibrinogen; Humans; Integrin beta3; Male; Oligopeptides; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Primary Cell Culture; Thrombelastography | 2017 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Dalteparin; Female; Fetal Growth Retardation; Fibrin; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Placenta; Placenta Diseases; Platelet Aggregation Inhibitors; Pregnancy | 2017 |
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Aspirin; Blood Platelets; Breast Neoplasms; Caco-2 Cells; Calcium Chloride; Colorectal Neoplasms; Female; Fibrin; Fibrinogen; Humans; Integrin alpha2; MCF-7 Cells; Platelet Activation; Platelet Aggregation; Thromboxane A2; Type C Phospholipases | 2018 |
Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Topics: Aged; Aspirin; Blood Coagulation; Coronary Artery Disease; Fibrin; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Nephelometry and Turbidimetry; Prognosis; Survival Analysis; Thrombosis | 2020 |
Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid.
Topics: Acetylation; Aspirin; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Fibrinolysis; Humans; Proteomics | 2021 |
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Fibrin; Humans; Neoplasm Recurrence, Local; Thrombosis; Urinary Bladder Neoplasms; Warfarin | 2022 |
Multiple cerebral infarctions due to calcified amorphous tumor growing rapidly from an antecedent infection and decreasing rapidly by detachment of fibrin and antithrombotic drugs: a case report.
Topics: Anti-Bacterial Agents; Aspirin; Calcinosis; Calcium; Cerebral Infarction; Female; Fibrin; Fibrinolytic Agents; Hallucinations; Heart Neoplasms; Humans; Inflammation; Neoplasm Recurrence, Local | 2022 |
Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions.
Topics: Alprostadil; Aspirin; Blood Coagulation; Blood Platelets; Collagen; Fibrin; Humans; Platelet Aggregation Inhibitors; Thrombin; Ticagrelor | 2023 |